"The filing in the U.S. is a very important milestone for simeprevir, the hepatitis C patients and for Medivir as a company.
http://www.businesswire.com/news/topix/20130328006319/en
http://www.businesswire.com/news/topix/20130328006319/en
HIV/AIDS News: News on HIV/AIDS continually updated from thousands of sources monitored by the B Media Network.